Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty

Journal of Shoulder and Elbow Arthroplasty · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles